Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro

Molecular Immunology

Volumn 44, Issue 8, 2007, Pages 2115-2123

  Goecke, I Annelise ^a,b   Alvarez, Claudia ^b   Henríquez, Juan ^b   Salas, Karime ^b   Molina, María Luisa ^b   Ferreira, Arturo ^b   Gatica, Héctor ^a  

^a Department of Neurology   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Autoimmunity; Glucocorticoid receptor (GCR); Glucocorticoid receptor beta; Methotrexate

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; ADENOSINE; ADENOSINE A2 RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHOTREXATE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; 3,7-DIMETHYL-1-PROPARGYLXANTHINE; DRUG DERIVATIVE; GLUCOCORTICOID RECEPTOR; IMMUNOSUPPRESSIVE AGENT; ISOPROTEIN; THEOBROMINE; VASODILATOR AGENT;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL; SENSITIVITY ANALYSIS; ASTHMA; AUTOIMMUNE DISEASE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; METABOLISM;

ADENOSINE; ASTHMA; AUTOIMMUNE DISEASES; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; JURKAT CELLS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; METHOTREXATE; PROTEIN ISOFORMS; RECEPTORS, ADENOSINE A2; RECEPTORS, GLUCOCORTICOID; THEOBROMINE; VASODILATOR AGENTS;

EID: 37849184958     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.07.303     Document Type: Article

References (47)

1. Ahn S.Y., and Kim D.S. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand. J. Rheumatol. 34 (2005) 136-139
2. Bamberger C.M., Bamberger A.M., de Castro M., and Chrousos G.P. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Inv. 95 (1995) 2435-2441
3. Boumpas D.T., Chrousos G.P., Wilder R.L., Cupps T.R., and Balow J.E. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Int. Med. 119 (1993) 1198-1208
4. Carmichael S.J., Beal J., Day R.O., and Tett S.E. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. J. Rheumatol. 29 (2002) 2077-2083
5. Chan E.S.L., and Cronstein B.N. Molecular actions of Methotrexate in inflammatory diseases. Arthritis Res. 4 (2002) 266-273
6. Corrigan C.H. Asthma refractory to glucocorticoids: the role of newer immunosuppressants. Am. J. Respir. Med. 1 (2002) 47-54
7. Corrigan C.H., Shiner R., Shakur B.H., and Ind P.W. Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition. Clin. Exp. Allergy 33 (2003) 1090-1096
8. Cronstein B.N., Naime D., and Ostad E. The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92 (1993) 2675-2682
9. Cronstein B.N. Molecular therapeutics: methotrexate and its mechanism of action. Arthritis Rheum. 39 (1996) 1951-1960
10. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76 (1994) 5-13
11. Cronstein B.N. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57 (2005) 163-172
12. Cutolo M., Seriolo B., Pizzorni C., Craviotto C., and Suli A. Methotrexate in psoriatic artritis. Clin. Exp. Rheumatol. 20 (2002) S76-S80
13. Cutolo M., Sulli A., Pizzorni C., Seriolo B., and Straub R.H. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60 (2001) 729-735
14. Degroot K., Rasmussen N., Bacon P.A., Tervaert J.W., Feighery C., Gregorini G., Gross W.L., Luqmani R., and Jayne D.R. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 52 (2005) 2461-2469
15. Dolían R.J., Tak P.P., Dijkmans B.A., De Kuiper P., Breedveld F.C., and Miltenburg A.M. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br. J. Rheumatol. 37 (1998) 502-508
16. Farber S., Diamond K.K., Mercer R.D., Sylvester R.F., and Wolff J.A. Temporary remissions in acute leukemia in Children produced by folic antagonist 4-amethopteroylglutamic acid (aminopterin). New Engl. J. Med. 238 (1948) 789-793
17. Feagan B.G., Fedorak R.N., Irvine E.J., Wild G., Sutherland L., Steinhart A.H., Greenberg G.R., Koval J., Wong C.J., Hopkins M., Hanauer S.B., and McDonald J.W. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease: North American Crohn's study group investigators. N. Engl. J. Med. 342 (2000) 1627-1632
18. Giaccone L., Martin P., Carpenter P., Moravec C., Hooper H., Funke V.A., Storb R., and Flowers R.E. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant. 36 (2005) 337-341
19. Goecke A., and Guerrero J. Glucocorticoid receptor β in acute and chronic inflammatory conditions: clinical implications. Immunobiology 211 (2006) 85-96
20. Goleva E., Li L.B., Eves P.T., Strand M.J., Martin R.J., and Leung D.Y. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid insensitive asthma. Am. J. Respir. Crit. Care. Med. 173 (2005) 607-616
21. Gougat C., Jaffuel D., Gagliardo R., Henriquet C., Bousquet J., Demoly P., and Mathieu M. Overexpression of the human glucocorticoid receptor α and β isoforms inhibits AP-1 and NF-κB activities hormone independently. J. Mol. Med. 80 (2002) 309-318
22. Hasko G.B., and Cronstein N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25 (2004) 33-39
23. Herman S., Zurgil N., and Deutsch M. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm. Res. 54 (2005) 273-280
24. Hew M., Bhavsar P., Torrego A., Meah S., Khorasani N., Barnes P.J., Adcock I., and Chung K.F. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am. J. Respir. Crit. Care. Med. 174 (2006) 134-141
25. Hildner K., Finotto S., Becker C., Schlaak J., Schirmacher P., Galle P.R., Marker-Hermann P., and Neurath M.F. Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis. Clin. Exp. Immunol. 118 (1999) 137-146
26. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompsom E.B., and Evans M.G. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635-641
27. Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., and Kohgo Y. Expresión of Glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118 (2000) 859-866
28. Kremer J.M. Towards a better understanding of methotrexate. Arthritis Rheum. 50 (2004) 1370-1382
29. Langford C.A., Sneller M.C., and Hoffman G.S. Methotrexate use in systemic vasculitis. Rheum. Dis. Clin. North. Am. 23 (1997) 841-853
30. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell. 18 (2005) 331-342
31. Metzler C., Hellmich B., Gause A., Gross W.L., and de Groot K. Churg strauss syndrome-successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin. Exp. Rheumatol. 22 (2004) S52-S61
32. Montesinos M.C., Desai A., Delano D., Chen J.F., Fink J.S., Jacobson M.A., and Cronstein B.N. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 48 (2003) 240-247
33. Nash R.A., Pineiro L.A., Storb R., Deeg H.J., Fitzsimmonds W.E., Furlong T., Hansen J.A., Gooley T., Maher R.M., Martin P., McSweeney P.A., Sullivan K.M., Anasetti C., and Fay J.V. F.K. 506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 88 (1996) 3634-3641
34. Oakley R.H., Sar M., and Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative functions. J. Biol. Chem. 271 (1996) 9550-9559
35. Oakley R.H., Webster J.C., Sar Jr. M., Parker C.R., and Cidlowski J.A. Expression and subcellular distribution of the β isoform of the human glucocorticoid receptor. Endocrinology 138 (1997) 5028-5038
36. Orii F., Ashida T., Nomura M., Maemoto A., Fujiki T., Ayabe T., Imai S., Saitoh Y., and Kohgo Y. Quantitative analysis for human glucocorticoid receptor α/β mRNA in IBD. Biochem. Biophys. Res. Com. 296 (2002) 1286-1294
37. Rai T., Ohira H., Tojo J., Abe K., Yokokawa J., Takiguchi J., Shishido S., and Sato Y. Expression of human glucocorticoid receptor in lymphocytes of patients with autoimmune hepatitis. Hepatol. Res. 29 (2004) 148-152
38. Sitkovsky M.V., and Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?. Trends Immunol. 26 (2005) 299-304
39. Sousa A.R., Lane S.J., Cidlowski J.A., Staynov D.Z., and Lee T.H. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform. J. Allergy Clin. Immunol. 105 (2000) 943-950
40. Suarez-Almazor, M.E., Belseck, E., Shea, B., Wells, G., Tugwell, P., 2000. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2.
41. Truss M., and Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14 (1993) 459-478
42. Vrugt B., Wilson S., Bron A., Shute J., Holgate S.T., Djukanovic R., and Aalbers R. Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T-cell proliferation. Eur. Resp. J. 15 (2000) 478-485
43. Webster J.C., Oakley R.H., Jewell C.M., and Cidlowski J.A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expressionand lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6865-6870
44. Xu Q., Leung Y.M., and Kisich K.O. Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor β in neutrophils. J. Biol. Chem. 278 (2003) 27112-27118
45. Yadav R., Misra R., and Naik S. In vitro effect of gold sodium thiomalate and methotrexate on tumor necrosis factor production in normal healthy individuals and patients with rheumatoid arthritis. Int. J. Immunopharmacol. 19 (1997) 111-114
46. Yudt M.R., and Cidlowski J.A. The glucocorticoid receptor: coding a diversity of proteins and responses trough a single gene. Mol. Endocrinol. 16 (2002) 1719-1726
47. Zhou J., and Cidlowski J.A. The human glucocorticoid receptor: one gen, multiple proteins and diverse responses. Steroids 70 (2005) 407-417